SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 63 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $147,000 | +276.9% | 20,840 | +217.7% | 0.00% | – |
| Q1 2021 | $39,000 | -31.6% | 6,559 | -46.4% | 0.00% | – |
| Q4 2020 | $57,000 | +42.5% | 12,241 | +17.6% | 0.00% | – |
| Q3 2020 | $40,000 | -71.2% | 10,412 | +115.2% | 0.00% | – |
| Q2 2020 | $139,000 | +286.1% | 4,838 | +188.5% | 0.00% | – |
| Q1 2020 | $36,000 | +24.1% | 1,677 | +13.2% | 0.00% | – |
| Q4 2019 | $29,000 | – | 1,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,711,286 | $22,268,000 | 3.58% |
| NEA Management Company, LLC | 3,142,958 | $18,858,000 | 0.94% |
| Vivo Capital, LLC | 1,232,394 | $7,394,000 | 0.82% |
| RA Capital Management | 5,914,252 | $35,486,000 | 0.76% |
| Nan Fung Group Holdings Ltd | 177,900 | $1,067,000 | 0.68% |
| Ikarian Capital, LLC | 400,000 | $2,400,000 | 0.48% |
| SAMLYN CAPITAL, LLC | 2,929,195 | $17,575,000 | 0.33% |
| EAM Investors, LLC | 149,029 | $894,000 | 0.19% |
| TPG GP A, LLC | 1,885,939 | $11,316,000 | 0.18% |
| Ikarian Capital, LLC | 136,059 | $815,000 | 0.16% |